Read the fifth issue of Person-centred Care Insights. Step into the heart of person-centred care! Explore innovative projects within our network and access a range of resources, tools, training programs, and event updates. Plus, check out the latest publications driving the person-centred care movement forward.
The full list of questions and answers from the Person-centred care in practice webinar 'Take the LEAP: Harnessing Lived Experience for Best Care', held on Thursday 12 December 2024.
Knowledge and understanding of how to communicate with people with intellectual disability is vital for safe and high-quality health care. Using positive behaviour support involves strategies that address the needs of the person.
People with intellectual disability are often at higher risk of adverse effects from medications as the information about their medicine may be difficult to understand.
The Commission has established the Sepsis Program Oversight Group (Oversight Group) to provide strategic advice and guidance to inform program and project implementation. Members include people with lived experience of sepsis, as well as adult and paediatric clinical experts from around Australia.
These Frequently Asked Questions provides answers to commonly asked questions about the web tool's purpose, features, update frequency, development, data sources, consumer enquiry pathways and the role of the Commission.
This decision aid can be used with your doctor to help you decide whether to use antibiotics when you have a flare-up (exacerbation) of your chronic obstructive pulmonary disease (COPD).
This decision aid can be used with your doctor to help you decide whether to use antibiotics when you or your child has sinusitis (acute rhinosinusitis).
This issue includes items on prevention, oral health, medication safety, patient engagement, COVID-19, and more. Also covered are the latest from Australian Prescriber, BMJ Quality & Safety, Pediatric Quality & Safety, Public Health Research & Practice and International Journal for Quality in Health Care.
This resource accompanies the Psychotropic Medicines in Cognitive Disability or Impairment Clinical Care Standard. It describes what the quality statements mean for healthcare services and provides indicators to support local quality improvement activity.